CUVL
ClinuvelDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
Current thesis
Composite grade D from latest DB weights. Momentum 0.0 / Value 69.8
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
0
Value
70
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $16.55
Why
Momentum0 · Δ7d -
Value70 · Δ7d -
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
0
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
70
60% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 0.0 / Value 69.8
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$342.61M
Beta
0.96
Shares Out
50.41M
P/E (TTM)
17.3
P/S (TTM)
6.57
P/FCF (TTM)
16.30
Rev YoY
-0.6%
EPS YoY
-10.6%
Gross Margin
+63.6%
Op Margin
+48.1%
Net Debt
-$146.52M
Current Ratio
14.64
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology